Sullivan Lara
SEC CIK 1769457 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PYXS | Pyxis Oncology, Inc. | Pres, CEO, Dir | 2.40M | — | $81.4K | 8 | 2022-03-31 | 2023-09-14 |
Most active insiders at PYXS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dupont Jakob | Dir | — | $107.1K |
| 2 | Wadhane Jitendra | Prin Fin, Acct Off | — | — |
Sullivan Lara made no open-market trades at PYXS in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-09-18 | 2023-09-14+ | PYXS | Pyxis Oncology, Inc. | Sullivan Lara | Pres, CEO, Dir | S - Sale | $2.10 | -8,641 | 2.40M | -0.4% | -$18.2K |
| M | 2023-09-13 | 2023-09-11+ | PYXS | Pyxis Oncology, Inc. | Sullivan Lara | Pres, CEO, Dir | S - Sale | $2.27 | -27.9K | 2.60M | -1% | -$63.3K |
| 2023-09-13 | 2023-09-13 | PYXS | Pyxis Oncology, Inc. | Sullivan Lara | Pres, CEO, Dir | F - Tax | $2.13 | -184.7K | 2.41M | -7% | -$393.5K | |
| 2023-09-08 | 2023-09-07 | PYXS | Pyxis Oncology, Inc. | Sullivan Lara | Pres, CEO, Dir | A - Grant | $0.00 | +469.5K | 2.63M | +22% | $0 | |
| D | 2023-03-28 | 2023-03-24 | PYXS | Pyxis Oncology, Inc. | Sullivan Lara | Pres, CEO, Dir | A - Grant | $0.00 | +703.4K | 2.16M | +48% | $0 |
| 2023-01-03 | 2023-01-03 | PYXS | Pyxis Oncology, Inc. | Sullivan Lara | CEO, Dir | A - Grant | $0.00 | +95.7K | 1.45M | +7% | $0 | |
| 2022-04-15 | 2022-04-14 | PYXS | Pyxis Oncology, Inc. | Sullivan Lara | CEO, Dir | A - Grant | $0.00 | +315.3K | 1.36M | +30% | $0 | |
| 2022-04-04 | 2022-03-31 | PYXS | Pyxis Oncology, Inc. | Sullivan Lara | CEO, Dir | A - Grant | $0.00 | +742.6K | 1.04M | +249% | $0 |
Purchase Sale Sale after option exercise All abbreviations